Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDLZ vs MRNA✓SelectedUSD · MRNAMDLZ vs MRNA performance historyLatest closeAs of+0.90%11/20
Stock and ETF performance explorer

MDLZ vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+24.5%
MRNA return
-27.3%
Excess return
+51.7%
Maximum drawdown
-29.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.9%-2.2%+3.1%+0.9%
7D-1.9%-12.7%+10.8%-1.6%
30D+5.6%-20.7%+26.3%+6.0%
3M+4.3%+46.3%-42.0%+3.3%
6M+9.0%+305.2%-296.2%+3.5%
YTD+26.3%+561.2%-534.9%+16.8%
1Y+23.1%+772.1%-749.0%+12.2%
3Y+2.2%+147.0%-144.7%-3.2%
All+24.5%-27.3%+51.7%+18.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling